Mark Cuban's Cost Plus Drugs could save Medicare billions

Study shows Mark Cuban’s new generic drug company’s system could save taxpayers billions

Billionaire innovator Mark Cuban has figured out how to substantially reduce costs for generic prescription drugs with a new company he launched this year, however, and a recent study showed that the federal government could save several billion dollars if it used his company or adopted the same practices, the Daily Caller reported.

In January, Cuban launched a new company known as Cost Plus Drugs that makes use of a direct-to-consumer system that substantially reduces costs for generic prescription drugs by bypassing wholesale distributors, pharmacies, and insurance companies and shipping the product directly from the manufacturer to the individual.

Read about it...